Market Cap N/A
Revenue (ttm) 152.58M
Net Income (ttm) -41.57M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin -27.24%
Debt to Equity Ratio N/A
Volume 461,700
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list o...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: (650) 460-2551
Address:
1035 O’Brien Drive, Menlo Park, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:13 AM
Actionable Trade Alert for $BLLN: Market Context: $BLLN is currently trading at $104.02, positioned between its 60D high of $138.7 and low of $88.0. The RSI at 58.57 indicates a neutral to slightly bullish sentiment, suggesting room for upward movement without being overbought. Directional Bias: Given the RSI and the proximity to the 60D high, we maintain a bullish bias. The stock's recent price action shows potential for a breakout. Trade Plan: - Suggested Entry: $104.50 (slightly above the last close to confirm upward momentum) - Stop Loss: $91.50 (below the 60D low for risk management) - Take Profit Targets: 1. TP1: $115.00 (10.5% ROI) 2. TP2: $125.00 (19.8% ROI) 3. TP3: $122.00 (17.3% ROI) This plan offers a solid risk-reward ratio with a potential ROI exceeding 17% on TP3. Monitor price action closely for adjustments. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 6 at 12:22 AM
$BLLN Current Stock Price: $111.18
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:47 PM
Actionable Trade Alert for $BLLN: Market Context: $BLLN is currently trading at $104.02, positioned between its 60D high of $138.7 and low of $88.0. The RSI at 58.57 indicates a neutral to slightly bullish sentiment, suggesting room for upward movement without being overbought. Directional Bias: Given the RSI and the proximity to the 60D high, we maintain a bullish bias. The stock's recent price action shows potential for a breakout. Trade Plan: - Suggested Entry: $104.50 (slightly above the last close to confirm upward momentum) - Stop Loss: $91.50 (below the 60D low for risk management) - Take Profit Targets: 1. TP1: $115.00 (10.5% ROI) 2. TP2: $125.00 (19.8% ROI) 3. TP3: $122.00 (17.3% ROI) This plan offers a solid risk-reward ratio with a potential ROI exceeding 17% on TP3. Monitor price action closely for adjustments. https://privateprofiteers.com
0 · Reply
Annie_Preferred
Annie_Preferred Dec. 5 at 9:03 PM
$BLLN Oguzhan Atay ... will be famous like Jensen one day! $NVDA
0 · Reply
Annie_Preferred
Annie_Preferred Dec. 5 at 8:29 PM
$BLLN Congrats!
0 · Reply
Bazzzigar
Bazzzigar Dec. 5 at 6:09 PM
$BLLN out before 9th..
0 · Reply
Neeter
Neeter Dec. 5 at 3:45 PM
$BLLN Thats more like it. Earnings 12/9. Im looking for a positive report and forecast.
0 · Reply
IPOtweet
IPOtweet Dec. 4 at 10:15 PM
Renaissance Capital's November IPO Market Update. Watch here: https://etfs.renaissancecapital.com/videos/122/renaissance-capitals-november-2025-ipo-market-recap Read on: https://www.renaissancecapital.com/IPO-Center/News/115279/Renaissance-Capitals-November-IPO-Market-Update $BETA $CBC.X $BLLN $AERO.X $XZO
0 · Reply
Bazzzigar
Bazzzigar Dec. 4 at 8:34 PM
$BLLN join with HIMS
0 · Reply
Bazzzigar
Bazzzigar Dec. 4 at 6:54 PM
$BLLN better be out before 9th...
1 · Reply
Latest News on BLLN
BillionToOne: A Deserved Opening Day Boom

Nov 7, 2025, 3:17 AM EST - 4 weeks ago

BillionToOne: A Deserved Opening Day Boom


BillionToOne targets over $2 billion valuation in US IPO

Oct 17, 2025, 6:09 PM EDT - 7 weeks ago

BillionToOne targets over $2 billion valuation in US IPO


BillionToOne Launches IPO In Slowing IPO Market

Oct 13, 2025, 12:23 PM EDT - 7 weeks ago

BillionToOne Launches IPO In Slowing IPO Market


Molecular diagnostics firm BillionToOne files for US IPO

Oct 7, 2025, 6:17 PM EDT - 2 months ago

Molecular diagnostics firm BillionToOne files for US IPO


BillionToOne IPO Registration Document (S-1)

Oct 7, 2025, 5:30 PM EDT - 2 months ago

BillionToOne IPO Registration Document (S-1)


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:13 AM
Actionable Trade Alert for $BLLN: Market Context: $BLLN is currently trading at $104.02, positioned between its 60D high of $138.7 and low of $88.0. The RSI at 58.57 indicates a neutral to slightly bullish sentiment, suggesting room for upward movement without being overbought. Directional Bias: Given the RSI and the proximity to the 60D high, we maintain a bullish bias. The stock's recent price action shows potential for a breakout. Trade Plan: - Suggested Entry: $104.50 (slightly above the last close to confirm upward momentum) - Stop Loss: $91.50 (below the 60D low for risk management) - Take Profit Targets: 1. TP1: $115.00 (10.5% ROI) 2. TP2: $125.00 (19.8% ROI) 3. TP3: $122.00 (17.3% ROI) This plan offers a solid risk-reward ratio with a potential ROI exceeding 17% on TP3. Monitor price action closely for adjustments. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 6 at 12:22 AM
$BLLN Current Stock Price: $111.18
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:47 PM
Actionable Trade Alert for $BLLN: Market Context: $BLLN is currently trading at $104.02, positioned between its 60D high of $138.7 and low of $88.0. The RSI at 58.57 indicates a neutral to slightly bullish sentiment, suggesting room for upward movement without being overbought. Directional Bias: Given the RSI and the proximity to the 60D high, we maintain a bullish bias. The stock's recent price action shows potential for a breakout. Trade Plan: - Suggested Entry: $104.50 (slightly above the last close to confirm upward momentum) - Stop Loss: $91.50 (below the 60D low for risk management) - Take Profit Targets: 1. TP1: $115.00 (10.5% ROI) 2. TP2: $125.00 (19.8% ROI) 3. TP3: $122.00 (17.3% ROI) This plan offers a solid risk-reward ratio with a potential ROI exceeding 17% on TP3. Monitor price action closely for adjustments. https://privateprofiteers.com
0 · Reply
Annie_Preferred
Annie_Preferred Dec. 5 at 9:03 PM
$BLLN Oguzhan Atay ... will be famous like Jensen one day! $NVDA
0 · Reply
Annie_Preferred
Annie_Preferred Dec. 5 at 8:29 PM
$BLLN Congrats!
0 · Reply
Bazzzigar
Bazzzigar Dec. 5 at 6:09 PM
$BLLN out before 9th..
0 · Reply
Neeter
Neeter Dec. 5 at 3:45 PM
$BLLN Thats more like it. Earnings 12/9. Im looking for a positive report and forecast.
0 · Reply
IPOtweet
IPOtweet Dec. 4 at 10:15 PM
Renaissance Capital's November IPO Market Update. Watch here: https://etfs.renaissancecapital.com/videos/122/renaissance-capitals-november-2025-ipo-market-recap Read on: https://www.renaissancecapital.com/IPO-Center/News/115279/Renaissance-Capitals-November-IPO-Market-Update $BETA $CBC.X $BLLN $AERO.X $XZO
0 · Reply
Bazzzigar
Bazzzigar Dec. 4 at 8:34 PM
$BLLN join with HIMS
0 · Reply
Bazzzigar
Bazzzigar Dec. 4 at 6:54 PM
$BLLN better be out before 9th...
1 · Reply
Bazzzigar
Bazzzigar Dec. 4 at 6:53 PM
$BLLN join with HIMS BBAI
0 · Reply
Annie_Preferred
Annie_Preferred Dec. 4 at 5:13 PM
$BLLN You can become the 100th follower on ST... what an honor!
0 · Reply
PhishTourFunds
PhishTourFunds Dec. 4 at 4:03 AM
$BLLN 👀 Rollin since IPO
0 · Reply
Annie_Preferred
Annie_Preferred Dec. 4 at 12:56 AM
$BLLN People are naturally going to suspicious ... Elizabeth Holmes had repeatedly claimed that her now-defunct Silicon Valley biotech startup, once valued at $9 billion, had developed a revolutionary blood analyzer capable of testing for hundreds of diseases and conditions using only a few drops of blood from a finger. BUT THESE GUYS SEEM LIKE THE REAL DEAL!
0 · Reply
Bazzzigar
Bazzzigar Dec. 3 at 11:43 PM
0 · Reply
Neeter
Neeter Dec. 3 at 7:40 PM
$BLLN wow. Crazy expiration day. Earnings 12/9. I guess we'll see who gets it right. GL
0 · Reply
Annie_Preferred
Annie_Preferred Dec. 3 at 5:54 PM
$BLLN Name is discouraging ... has to be the problem!
0 · Reply
mollielatham
mollielatham Dec. 1 at 8:42 PM
$BLLN after 30 days u get these upgrades--many use them to sell--sold out this morning at 129--bt back just now at 112--
0 · Reply
Jb101010
Jb101010 Dec. 1 at 6:16 PM
$BLLN moon
0 · Reply
JarvisFlow
JarvisFlow Dec. 1 at 5:55 PM
Piper Sandler updates rating for BillionToOne ( $BLLN ) to Overweight, target set at 150.
0 · Reply
medguy
medguy Dec. 1 at 5:07 PM
$BLLN looking for a bounce
0 · Reply
JarvisFlow
JarvisFlow Dec. 1 at 4:14 PM
Stifel has adjusted their stance on BillionToOne ( $BLLN ), setting the rating to Buy with a target price of 145.
0 · Reply